Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation.
In chronic neurodegenerative diseases, microglial activation is an early sign that often precedes neuronal death. Increasing evidence indicates that in these chronic pathologies activated microglia sustain a local inflammatory response. Nonetheless, the potential detrimental or protective roles of such reaction remain to date not fully understood, mainly because of the lack of direct evidence of the functional properties acquired by microglia in the course of chronic diseases. Purified microglial cultures have been extensively used to investigate microglial functions associated with activation, but they are often criticized for some experimental constrains, including the abrupt addition of activators, the limited time of stimulation, and the absence of interactions with neurons or other elements of brain parenchyma. To limit these confounding factors, we developed in vitro models in which microglial cells were repeatedly challenged with lipopolysaccharide or co-cultured with healthy, apoptotic, or necrotic neuronal cells. We found that chronic stimulation and interaction with phosphatidylserine-expressing apoptotic cells induced microglial cells to release immunoregulatory and neuroprotective agents (prostaglandin E(2), transforming growth factor-beta, and nerve growth factor), whereas the synthesis of pro-inflammatory molecules (tumor necrosis factor-alpha and nitric oxide) was inhibited. These findings suggest that signals that are relevant to chronic diseases lead to a progressive down-regulation of pro-inflammatory microglial functions and may help in understanding the atypical microglial activation that begins to be recognized in some chronic neuropathologies.
Minghetti
Luisa
L
Department of Cell Biology and Neurosciences, Istituto Superiore Di Sanità, Italy. luisa.minghetti@iss.it
Ajmone-Cat
Maria Antonietta
MA
De Berardinis
Maria Anna
MA
De Simone
Roberta
R
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002908:Chronic Disease; D018920:Coculture Techniques / Q000379:methods; D015232:Dinoprostone / Q000378:metabolism; D006801:Humans; D017628:Microglia / Q000187:drug effects / Q000502:physiology*; D019636:Neurodegenerative Diseases / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009573:Nitrites / Q000378:metabolism; D011134:Polysaccharides / Q000008:administration & dosage; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D009573:Nitrites; D011134:Polysaccharides; D014409:Tumor Necrosis Factor-alpha; D015232:Dinoprostone